CMS Extends 2023 MIPS Submission and EUC Deadline

As the Year Comes to a Close The team at EyeMD EMR Healthcare Systems would like to extend our heartfelt gratitude for your trust and partnership over the past year. We deeply appreciate your continued support and wish you great success and a joyful start to the New Year. Important MIPS Deadlines As we approach year-end, please keep the following key dates in mind for the MIPS attestation process: December 31, 2024: End of the 2024 MIPS attestation period December 31, 2024: Deadline for the MIPS Extreme & Uncontrollable Circumstances (EUC) Exception and the Promoting Interoperability Hardship application (closes at 8:00 PM ET) January 1,

With the kids back in school, it’s time to catch up on your MIPS homework! That means it’s time for the Security Risk Assessment (SRA)! What is SRA? The Security Risk Analysis (SRA) is a critical process for both MIPS and HIPAA. Under MIPS, it directly impacts a provider’s performance score in the Promoting Interoperability (PI) category, while under HIPAA, it is a legal requirement to ensure the protection of electronic Protected Health Information (ePHI). MIPS (Merit-based Incentive Payment System): As part of the Promoting Interoperability (PI) category, healthcare providers are required to conduct or review a Security Risk Analysis (SRA) to protect electronic health

The Federal Trade Commission (FTC) Eyeglass Rule, officially titled 16 CFR Part 456, is a regulation that mandates eyecare providers to provide patients with a copy of their eyeglass prescription immediately after an eye examination. This rule applies regardless of whether the patient requests the prescription, and even if the examination does not indicate a change in the prescription.   The FTC Eyeglass Rule will go into effect September 2024.   Rule Highlights: Automatic Release of Prescription: After completing an eye exam, you must provide the patient with a copy of their eyeglass prescription, even if they do not ask for it. No Conditions or

Our support operations have been fully restored. Services for our credit card processing partner Nexio have also been fully restored. Eligibility checks for most carriers have been restored as well. A banner in the PM will provide status updates for the remaining carriers. We thank you for your patience and apologize for the inconvenience.

 A software update from the cybersecurity company CrowdStrike has inadvertently disrupted IT systems globally. Although most of our systems were unaffected, our primary remote support tool (LogMeIn Rescue) is currently offline. Consequently, our remote support capabilities have been impacted. Our support team is unable to access customer systems using this tool. However, we can connect to remote systems using an alternative, customer-initiated tool. As a result, we are unable to perform certain remote tasks, which may lead to support delays and cancellations. Additionally, our credit card processing partner, Nexio, is currently unable to process credit card transactions, and certain eligibility checks are failing. We thank

We are excited to introduce NewCrop Rx v2!   Our development team has been collaborating closely with our ePrescribing vendor to bring you the latest version of NewCrop Rx. The new platform is designed to enhance usability and reliability, offering a host of new features including: A fresh, modern, and intuitive interface. Real-time benefits information (including alternative drug options). Customized SIG builders. New drop-down menus and much more! To ensure a seamless transition, please review the Migration Guide prior to your transition.   To assist you in mastering the ePrescribing process and optimizing your transition experience, the following resources are also available: Get Started Guide